EA201270425A1 - Кристаллы и сшитые кристаллы белка а и способы их применения - Google Patents

Кристаллы и сшитые кристаллы белка а и способы их применения

Info

Publication number
EA201270425A1
EA201270425A1 EA201270425A EA201270425A EA201270425A1 EA 201270425 A1 EA201270425 A1 EA 201270425A1 EA 201270425 A EA201270425 A EA 201270425A EA 201270425 A EA201270425 A EA 201270425A EA 201270425 A1 EA201270425 A1 EA 201270425A1
Authority
EA
Eurasian Patent Office
Prior art keywords
crystals
methods
cross
application
linked protein
Prior art date
Application number
EA201270425A
Other languages
English (en)
Other versions
EA033141B1 (ru
Inventor
Бхами Шеной
Рина Пател
Сибил Балади
Маргарет Макграт
Назер Кхалаф
Чанчал Рандхава
Original Assignee
Альтеа Текнолоджиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Альтеа Текнолоджиз, Инк. filed Critical Альтеа Текнолоджиз, Инк.
Publication of EA201270425A1 publication Critical patent/EA201270425A1/ru
Publication of EA033141B1 publication Critical patent/EA033141B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Описаны кристаллы белка А и сшитые кристаллы белка А (CLPC). Также описаны способы получения и использования.
EA201270425A 2009-09-15 2010-09-13 Сшитые кристаллы белка а и их применение EA033141B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24253709P 2009-09-15 2009-09-15
PCT/US2010/048664 WO2011034822A1 (en) 2009-09-15 2010-09-13 Protein a crystals and cross-linked crystals and methods of use thereof

Publications (2)

Publication Number Publication Date
EA201270425A1 true EA201270425A1 (ru) 2013-02-28
EA033141B1 EA033141B1 (ru) 2019-09-30

Family

ID=43758972

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270425A EA033141B1 (ru) 2009-09-15 2010-09-13 Сшитые кристаллы белка а и их применение

Country Status (12)

Country Link
US (2) US8921531B2 (ru)
EP (1) EP2478005B1 (ru)
JP (1) JP5700581B2 (ru)
KR (1) KR101530417B1 (ru)
CN (1) CN102753570B (ru)
BR (1) BR112012005869A2 (ru)
CA (1) CA2774212C (ru)
DK (1) DK2478005T3 (ru)
EA (1) EA033141B1 (ru)
ES (1) ES2530578T3 (ru)
HK (1) HK1173457A1 (ru)
WO (1) WO2011034822A1 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2478005B1 (en) 2009-09-15 2014-11-12 Ajinomoto Althea, Inc. Protein a crystals and cross-linked crystals and methods of use thereof
JP5963538B2 (ja) * 2012-02-24 2016-08-03 三井造船株式会社 モーレラ属細菌の遺伝子組換え法
WO2014192877A1 (ja) * 2013-05-29 2014-12-04 Jsr株式会社 洗浄用組成物、タンパク質精製方法、及びタンパク質
CN105407905B (zh) 2014-01-03 2020-03-03 生物辐射实验室股份有限公司 蛋白a洗脱产物中杂质的去除
WO2016031932A1 (ja) * 2014-08-27 2016-03-03 田辺三菱製薬株式会社 アルカリ洗浄によるＦｃ領域を有するタンパク質の製造方法
AR103726A1 (es) * 2015-02-27 2017-05-31 Merck Sharp & Dohme Cristales de anticuerpos monoclonales anti-pd-1 humanos
BR112019011921A2 (pt) * 2016-12-12 2019-11-05 Hurrah S A R L polipeptídeo engenheirado que liga imunoglobulinas ou compostos contendo imunoglobulina, matriz de separação, composição, proteína, meio cromatográfico e método de purificação de uma imunoglobulina
RU2019138507A (ru) 2017-05-02 2021-06-02 Мерк Шарп И Доум Корп. Составы антител против lag3 и совместные составы антител против lag3 и антител против pd-1
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
CN112816700A (zh) * 2020-12-28 2021-05-18 杭州新脉生物科技有限公司 一种检测尿液中hiv抗体的胶体金试纸条

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS508549A (ru) 1973-05-21 1975-01-29
US5618710A (en) 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
IE912767A1 (en) * 1990-08-03 1992-02-12 Vertex Pharma Use of crosslinked crystals as a novel form of enzyme¹immobilization
AU628264B2 (en) 1990-08-14 1992-09-10 Oracle International Corporation Methods and apparatus for providing a client interface to an object-oriented invocation of an application
WO1997036614A1 (en) 1996-03-29 1997-10-09 Terman David S Polymerized staphylococcal protein a for treatment of diseases
US6140475A (en) 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
CN101120017A (zh) 2004-08-30 2008-02-06 英国龙沙生物医药股份有限公司 用于纯化抗体的亲和力加离子交换层析
EP2478005B1 (en) 2009-09-15 2014-11-12 Ajinomoto Althea, Inc. Protein a crystals and cross-linked crystals and methods of use thereof

Also Published As

Publication number Publication date
US20150239962A1 (en) 2015-08-27
KR101530417B1 (ko) 2015-06-19
EA033141B1 (ru) 2019-09-30
HK1173457A1 (zh) 2013-05-16
CA2774212A1 (en) 2011-03-24
WO2011034822A1 (en) 2011-03-24
ES2530578T3 (es) 2015-03-03
CN102753570B (zh) 2016-01-20
BR112012005869A2 (pt) 2017-01-31
CA2774212C (en) 2018-01-30
EP2478005A4 (en) 2013-07-24
DK2478005T3 (en) 2015-02-16
US20130053548A1 (en) 2013-02-28
JP5700581B2 (ja) 2015-04-15
EP2478005B1 (en) 2014-11-12
KR20140002459A (ko) 2014-01-08
CN102753570A (zh) 2012-10-24
EP2478005A1 (en) 2012-07-25
JP2013504621A (ja) 2013-02-07
US9273123B2 (en) 2016-03-01
US8921531B2 (en) 2014-12-30

Similar Documents

Publication Publication Date Title
EA201270425A1 (ru) Кристаллы и сшитые кристаллы белка а и способы их применения
CY1125705T1 (el) Πρωτεϊνες προσδεσης καλλικρεϊνης πλασματος
EA201300239A1 (ru) Антитела к fap и способы их применения
EA201390929A1 (ru) Антитела к pcsk9 и способы их применения
EA201270571A1 (ru) Человеческие il-23-антигенсвязывающие белки
BR112013004776A2 (pt) moduladores de proteína notum e métodos de uso
ES2585388T5 (es) Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
EA201171494A1 (ru) Миметики белка smac
EA201290880A1 (ru) Новые соединения - ингибиторы фермента
DK3290024T3 (da) Vedvarende indgivelse af aktive midler til behandling af glaukom og okulær hypertension
EA201170212A1 (ru) Охлаждение и обработка материалов
BR112013014119A8 (pt) Novos moduladores e métodos de uso
BR112013005116A2 (pt) moduladores e métodos de uso
EA201170242A1 (ru) Модифицированные бычьи полипептиды g-csf и их применение
EA201391019A1 (ru) Соединения и способы для модуляции киназ, а также показания к их применению
GT201400057A (es) 3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante
BR112012000934A2 (pt) cassetes e métodos de utilizacao destes
CL2009001032A1 (es) Combinaciones de compuestos activos para controlar plagas animales; uso de las combinaciones; y procedimientos para controlar plagas animales.
EA201300730A1 (ru) Производные индазолилтриазола
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
EA201270722A1 (ru) Формы рифаксимина и их применение
EA200971077A1 (ru) Гетероциклические модуляторы киназы
BRPI1015350A2 (pt) anticorpos de anti-ceacam1 e métodos de usar os mesmos
EA201691430A1 (ru) Лечение портальной гипертензии и восстановление функции печени с помощью l-орнитинфенилацетата
EA201101521A1 (ru) Способы лечения онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU